LIANY — LianBio Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-Phillips 66, Amazon.com Inc, Abbvie Inc
U.S. STOCKS ON THE MOVE-Tesla Inc, LianBio, Intel Corp
LianBio rises as partner Bristol's heart disease drug gets U.S. approval
Brief: Lianbio's Partner Reviral Enters Into Acquisition Agreement With Pfizer
Pfizer's Reviral deal a potential boost for LianBio - Jefferies
Brief: LianBio Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: Lianbio Issues Statement Regarding The HFCAA
China's Meihua jumps in U.S. debut after IPO size slashed
U.S. STOCKS ON THE MOVE-Gold stocks, AMC, Tower Semiconductor, Nvidia
LianBio jumps as cardiac drug gets breakthrough therapy tag in China
Brief: Lianbio Announces Mavacamten Granted Breakthrough Therapy Designation In China
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
Brief: Lianbio Announces Infigratinib Approved Under Special Named Patient Program For The Treatment Of Cholangiocarcinoma In The Pilot Zone Of Hainan Province In China
Brief: LianBio Provides Corporate Update And Reports Third Quarter 2021 Financial Results
U.S. RESEARCH ROUNDUP- Agnico Eagle Mines, Dick's Sporting Goods, Linde
Chinese IPOs return to New York with a whimper
Brief: LianBio ADSs Open 3.1% Below IPO Price in Nasdaq Debut
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:59 AM
Brief: Lianbio Announces Pricing Of Initial Public Offering